Pharmaceutical Disposal Mailer With Activated Carbon Neutralization

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

There is a need for a safe and easy system and method for disposing of unwanted pharmaceutical formulations, as improper disposal can lead to environmental contamination and potential abuse, and existing methods like flushing or throwing them away pose risks to the environment and public health.

Innovation Solution

A system comprising a disposal container preloaded with a pharmacological agent activity mitigation component, such as activated carbon or a sequestering agent, combined with the unwanted pharmaceutical formulation, sealed, and shipped in a direct mail mailer that meets USPS automation flat requirements, ensuring safe disposal.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Ease of operation

If pharmaceutical formulations are flushed down the toilet or thrown into the trash, then disposal is simple and quick, but environmental contamination occurs and public health is at risk

Engineering Contradiction:
Improvedisposal simplicityVSAvoidenvironmental contamination
Core Design Contradiction:
Ease of operationVSObject-affected harmful factors

Solution Approach 1:

The patent introduces an intermediary substance (absorbent material, chemical neutralizing agent, or activated carbon) that mediates between the pharmaceutical formulation and the environment. This intermediary absorbs or neutralizes the pharmaceutical components, preventing them from contaminating the environment while maintaining simple disposal procedures for the consumer.

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The patent converts the harmful pharmaceutical formulation into a benign substance through chemical neutralization or absorption processes. The harmful active ingredients are transformed into inactive compounds or trapped within absorbent materials, turning a dangerous waste product into something safe for environmental disposal.

Inventive Principle:
Principle #22Blessing in disguise (Convert harm into benefit)

2Ease of operation

If controlled substances are kept available at home, then access is convenient, but potential for abuse increases

Engineering Contradiction:
Improveaccess convenienceVSAvoidabuse potential
Core Design Contradiction:
Ease of operationVSObject-generated harmful factors

Solution Approach 1:

The patent enables preliminary disposal action by providing consumers with disposal kits containing neutralizing agents or absorbent materials. This allows immediate neutralization of controlled substances at the point of disposal, preventing future abuse opportunities while maintaining convenience through a simple mail-back process.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The patent extracts the harmful active ingredients from the pharmaceutical formulation through absorption or chemical reaction. The active pharmaceutical ingredients are removed from circulation by being absorbed into materials like activated carbon or chemically neutralized, eliminating the abuse potential while maintaining a simple consumer process.

Inventive Principle:
Principle #2Taking out (Extraction)

3Reliability

If a disposal system uses specialized packaging and mitigation components, then safety and environmental protection are improved, but device complexity and cost increase

Engineering Contradiction:
Improvedisposal safetyVSAvoidpackaging complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent creates a universal disposal kit that handles multiple types of pharmaceutical formulations (controlled substances, non-controlled, different dosage forms) using the same basic components. The disposal container, absorbent material, and mailer serve multiple functions: containment, neutralization, protection, and transportation, eliminating the need for different systems for different medication types.

Inventive Principle:
Principle #6Universality (Multi-functionality)

Solution Approach 2:

The patent merges multiple disposal functions into a single integrated mailer package. The disposal container, neutralizing agents, absorbent materials, and shipping packaging are combined into one pre-assembled unit that consumers can use immediately. This consolidation simplifies the consumer experience while maintaining comprehensive safety features.

Inventive Principle:
Principle #5Merging (Combining)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The system effectively mitigates the environmental impact of pharmaceuticals by neutralizing their active ingredients and ensures safe disposal through a cost-effective, user-friendly process that complies with postal regulations.

Implementation Method 1

combining the unwanted pharmaceutical formulation with a pharmacological agent activity mitigation component in a disposal container

Methodology Applied
Scientific EffectAdsorption: Adsorption

Implementation Method 2

The pharmacological agent activity mitigation component may be activated carbon

Methodology Applied
Scientific EffectActivated carbon: Activated Carbon

Data Source

PatentUS12544813B2Unwanted pharmaceutical formulation disposal system and mailer
Publication Date: 2026.02.10 VERDE ENVIRONMENTAL TECHNOLOGIES INC
  • US12544813B2 patent drawing
  • US12544813B2 patent drawing
  • US12544813B2 patent drawing

AI summary

Systems and methods that an individual may use for disposing of unwanted pharmaceutical formulation. More specifically, systems and methods that an individual may use for disposing of unwanted pharmaceutical formulations that include receiving a disposal container including a pharmacological agent activity mitigation component and combining the unwanted pharmaceutical formulation with the pharmacological agent activity mitigation component in the disposal container are provided. The systems and method may further include a direct mail mailer for sending the disposal container and pharmacological agent activity mitigation component to the user.